Relationship between Monocyte-to-HDL Cholesterol Ratio and Short-term Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis

doi:10.3969/j.issn.1673-5765.2020.02.006

Abstract

Abstract:

Objective To investigate the relationship between monocyte-to-HDL cholesterol ratio (MHR) and short-term prognosis in acute ischemic stroke (AIS) patients treated with intravenous thrombolysis. Methods A retrospective analysis of consecutive AIS patients treated with intravenous thrombolysis in Department of Neurology of the First Affiliated Hospital of Zhengzhou University from January 2015 to December 2017 was undertaken. Functional outcome at 90 days was evaluated by the mRS. Good outcome was defined as a mRS score of 0-2. Multivariate logistic regression analysis was conducted to evaluate the relationship between MHR and 90-day outcome. The ROC curve analysis was performed to evaluate the predictive value. Results A total of 281 patients were included, with an average age of 59.54±12.49 years and 183 males (65.1%). 223 cases (79.4%) had good prognosis. Multivariate analysis showed that higher age (OR 1.03, 95%CI 1.01-1.06, P=0.013), baseline NIHSS score (OR 1.31, 95%CI 1.17-1.44, P<0.001) and MHR (OR 2.39, 95%CI 1.10-5.25, P=0.028) were independent predictors for 90-day poor prognosis. Subgroup analysis showed that high MHR (OR 5.15, 95%CI 1.28-20.77, P=0.021) was an independent predictor for 90-day poor prognosis in patients with large atherosclerotic stroke. ROC curve analysis showed that the optimal cut-off point of MHR was 0.48, and the sensitivity and specificity of predicting short-term poor prognosis were 79.41% and 58.33%. Conclusions MHR was an independent predictor for short-term prognosis after venous thrombolysis in AIS patients, especially in patients with large atherosclerotic stroke.

Key words: Acute ischemic stroke; Monocyte; High density lipoprotein; Thrombolysis;Prognosis

摘要：

目的探讨单核细胞与HDL-C比值（monocyte-to-HDL cholesterol ratio，MHR）与急性缺血性卒中（acute ischemic stroke，AIS）静脉溶栓短期预后的关系。方法回顾性纳入2015年1月1日-2017年12月1日在郑州大学第一附属医院神经内科急诊接受静脉溶栓治疗的AIS患者。患者预后通过90 d mRS来评估，良好预后定义为mRS评分≤2分。采用多因素 Logistic回归分析MHR及其他基线资料与90 d预后的关系，应用ROC曲线评价MHR对预后的预测价值。结果共纳入281例患者，平均年龄59.54±12.49岁，男性183例（65.1%），良好预后223例（79.4%）。多因素Logistic回归分析显示，高龄（OR 1.03，95%CI 1.01～1.06，P =0.013）、溶栓前NI HSS评分高（OR 1.31，95%CI 1.17～1.44，P＜0.001）和高MHR（OR 2.39，95%CI 1.10～5.25，P =0.028）是AIS静脉溶栓患者90 d不良预后的独立影响因素。亚组分析显示，高MHR（OR 5.15，95%CI 1.28～20.77，P =0.021）是大动脉粥样硬化型AIS静脉溶栓90 d不良预后的独立影响因素。ROC曲线分析显示，MHR预测预后不良的最佳界值为0.48，其敏感度和特异度分别为79.41%和58.33%。结论 MHR是AIS尤其大动脉粥样硬化型静脉溶栓短期预后的独立影响因素。

关键词: 急性缺血性卒中; 单核细胞; 高密度脂蛋白; 溶栓; 预后

LIU Hong-Bing, LIU Kai, PEI Lu-Lu, GAO Yuan, ZHAO Lu, FANG Hui, SONG Bo, XU Yu-Ming. Relationship between Monocyte-to-HDL Cholesterol Ratio and Short-term Outcome in Acute Ischemic Stroke Patients Treated with Intravenous Thrombolysis[J]. Chinese Journal of Stroke, 2020, 15(02): 141-145.

刘红兵，刘凯，裴璐璐，高远，赵璐，方慧，宋波，许予明. 单核细胞与高密度脂蛋白胆固醇比值与急性缺血性卒中静脉溶栓短期预后的关系[J]. 中国卒中杂志, 2020, 15(02): 141-145.

References

[1] WANG Y L，WU D，LIAO X，et al. Burden of

stroke in China[J]. Int J Stroke，2007，2（3）：211-

213.

[2] LIBERALE L，MONTECUCCO F，

BONAVENTURA A，et al. Monocyte count at

onset predicts poststroke outcomes during a 90-day

follow-up[J]. Eur J Clin Invest，2017，47（10）：702-

710.

[3] ZHOU X，YU F，FENG X，et al. Immunity and

inflammation predictors for short-term outcome of

stroke in young adults[J]. Int J Neurosci，2018，128

（7）：634-639.[4] CICEK G，KUNDI H，BOZBAY M，et al. The

relationship between admission monocyte HDL-C

ratio with short-term and long-term mortality among

STEMI patients treated with successful primary

PCI[J]. Coron Artery Dis，2016，27（3）：176-184.

[5] GANJALI S，GOTTO A M Jr，RUSCICA M，et al.

Monocyte-to-HDL-cholesterol ratio as a prognostic

marker in cardiovascular diseases[J]. J Cell Physiol，

2018，233（12）：9237-9246.

[6] DOGAN A，OYLUMLU M. Increased monocyte-to-

HDL cholesterol ratio is related to cardiac syndrome

X[J]. Acta Cardiol，2017，72（5）：516-521.

[7] BOLAYIR A，GOKCE S F，CIGDEM B，et al.

Monocyte/high-density lipoprotein ratio predicts

the mortality in ischemic stroke patients[J]. Neurol

Neurochir Pol，2018，52（2）：150-155.

[8] 中华医学会神经病学分会脑血管病学组急性缺血性

脑卒中诊治指南撰写组. 中国急性缺血性脑卒中诊

治指南2010[J]. 中华神经科杂志，2010，43（2）：146-

153.

[9] GOYAL N，TSIVGOULIS G，CHANG J J，et

al. Admission neutrophil-to-lymphocyte ratio as a

prognostic biomarker of outcomes in large vessel

occlusion strokes[J]. Stroke，2018，49（8）：1985-

1987.

[10] 刘新萍，佡剑非. 单核细胞/高密度脂蛋白比值对动

脉粥样硬化影响的研究进展[J]. 卒中与神经疾病，

2018，25（6）：743-745.

[11] NOZAWA N，HIBI K，ENDO M，et al. Association

between circulating monocytes and coronary plaque

progression in patients with acute myocardial

infarction[J]. Circ J，2010，74（7）：1384-1391.

[12] PARK S，ZHU J，ALTAN-BONNET G，et al.

Monocyte recruitment and activated inflammation

are associated with thyroid carcinogenesis in a

mouse model[J]. Am J Cancer Res，2019，9（7）：

1439-1453.

[13] PENG H，NING H，WANG Q，et al. Monocyte

chemotactic protein-induced protein 1 controls

allergic airway inflammation by suppressing IL-

5-producing TH2 cells through the Notch/Gata3

pathway[J]. J Allergy Clin Immunol，2018，142（2）：582-594.

[14] QIAO J H，TRIPATHI J，MISHRA N K，et al.

Role of macrophage colony-stimulating factor in

atherosclerosis：studies of osteopetrotic mice[J]. Am

J Pathol，1997，150（5）：1687-1699.

[15] HANEMANN A L，LIBORIO A B，DAHER E

F，et al. Monocyte chemotactic protein-1（MCP-

1）in patients with chronic schistosomiasis mansoni：

evidences of subclinical renal inflammation[J/OL].

PLoS One，2013，8（11）：e80421[2019-09-13]. https：

//doi.org/10.1371/journal.pone.0080421.

[16] EBTEHAJ S，GRUPPEN E G，PARVIZI M，et

al. The anti-inflammatory function of HDL is

impaired in type 2 diabetes：role of hyperglycemia，

paraoxonase-1 and low grade inflammation[J].

Cardiovasc Diabetol，2017，16（1）：132.

[17] MURPHY A J，WOOLLARD K J，HOANG A，et

al. High-density lipoprotein reduces the human

monocyte inflammatory response[J]. Arterioscler

Thromb Vasc Biol，2008，28（11）：2071-2077.

[18] 赵战芝，姜志胜. 高密度脂蛋白在动脉粥样硬化相关

免疫和炎症反应中的双重作用[J]. 中国动脉硬化杂

志，2007，15（12）：953-957.

[19] WELTY F K. How do elevated triglycerides and

low HDL-cholesterol affect inflammation and

atherothrombosis?[J]. Curr Cardiol Rep，2013，15

（9）：400.

[20] ZHU X，PARKS J S. New roles of HDL in

inflammation and hematopoiesis[J]. Annu Rev Nutr，

2012，32：161-182.

[21] CETIN M S，OZCAN CETIN E H，KALENDER

E，et al. Monocyte to HDL cholesterol ratio predicts

coronary artery disease severity and future major

cardiovascular adverse events in acute coronary

syndrome[J]. Heart Lung Circ，2016，25（11）：1077-

1086.

[22] YOU S，ZHONG C，ZHENG D，et al. Monocyte to

HDL cholesterol ratio is associated with discharge

and 3-month outcome in patients with acute

intracerebral hemorrhage[J]. J Neurol Sci，2017，372：

157-161.